Added to YB: 2024-09-12
Pitch date: 2024-09-12
NAMS [bullish]
NewAmsterdam Pharma Company N.V.
+115.63%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease.
Market Cap
$3.9B
Pitch Price
$16.06
Price Target
N/A
Dividend
N/A
EV/EBITDA
-15.64
P/E
-17.75
EV/Sales
89.97
Sector
Biotechnology
Category
N/A
Show full summary:
NEWAMSTERDAM PHARMA COMPANY NAMS
A summary for this pitch has not been created yet.
Read full article (0 min)